|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.400 USD | +1.27% |
|
-0.41% | +33.33% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | 12.31x | - | - | - | - | 193M | ||
| 0.56% | 0.63% | 35.56x | 21.72x | 12.7x | 26.67x | 27.73x | 1,068B | ||
| 2.02% | 2.12% | 28.51x | 7.24x | 6.52x | 18.04x | 19.59x | 641B | ||
| 2.68% | 2.81% | 32.33x | 12787.95x | 7.59x | 15.6x | 16.11x | 454B | ||
| 2.78% | 2.84% | 19.49x | 7.29x | 4.75x | 11.79x | 13.16x | 351B | ||
| 2.78% | 2.9% | 22.29x | 6.28x | 5.76x | 14.37x | 15.23x | 299B | ||
| 1.93% | 2.05% | 21.47x | 4.92x | 4.5x | 12.72x | 13.54x | 266B | ||
| 3.48% | 3.39% | 14.4x | 6.36x | 5.35x | 11.02x | 12.97x | 220B | ||
| 2.68% | 2.83% | 24.71x | 18.98x | 6.49x | 11.44x | 14.84x | 203B | ||
| 2.53% | 2.61% | -47.03x | 8.25x | 5.64x | 31.15x | 61.96x | 162B | ||
| 6.98% | 7.05% | 12.52x | 1.6x | 3.08x | 7.78x | 8.79x | 141B | ||
| 4.03% | 4.11% | 12.14x | 5.49x | 3.3x | 8.9x | 9.52x | 128B | ||
| -.--% | -.--% | 27.31x | 5.49x | 8.27x | 18.63x | 19.52x | 122B | ||
| 5.47% | 5.79% | 11.7x | 1.25x | 2.19x | 7.03x | 8.01x | 106B | ||
| 3.55% | 3.73% | 12.36x | 4.52x | 2.76x | 7.98x | 9.12x | 104B | ||
| 1.99% | 2.3% | 22.21x | 5.01x | 7.39x | 14.02x | 14.67x | 68.84B | ||
| 3.54% | 3.62% | 46.96x | 1.24x | 2.82x | 10x | 28.91x | 56.28B | ||
| 0.48% | 1.33% | 20.42x | 1.65x | 1.72x | 8.14x | 13.67x | 52.78B | ||
| 0.5% | 0.56% | 38.44x | 5.14x | 8.68x | 28.81x | 30.12x | 52.23B | ||
| 2.16% | 2.4% | 19.12x | 1.93x | 3.47x | 13.01x | 14.61x | 43.39B | ||
| Average | 2.64% | 2.79% | 19.36x | 679.07x | 5.42x | 14.58x | 18.53x | 226.86B | |
| Weighted average by Cap. | 2.22% | 2.32% | 23.79x | 1,288.88x | 7.25x | 17.38x | 19.91x |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















